Categorie > Urology / Nephrology

Pancreatic And Psoas Abscesses As A Late Complication Of Intravesical Administration Of BCG For Bladder Cancer: Case Report And Literature Review

Categorie : Urology / Nephrology
UroToday.com - Bacillus Calmette-Guerin (BCG) is a live attenuated strain of Mycobacterium bovis that has been used to treat urothelial carcinoma since 1976, and has been reported to eradicate disease in more than 70% of patients with in situ and stage I disease... ...

read more UroToday.com - Bacillus Calmette-Guerin (BCG) is a live attenuated strain of Mycobacterium bovis that has been used to treat urothelial carcinoma since 1976, and has been reported to eradicate disease in more than 70% of patients with in situ and stage I disease... read more Fri Mar 2010

Objective Differences Between Overactive Bladder Patients With And Without Urodynamically Proven Detrusor Overactivity

Categorie : Urology / Nephrology
UroToday.com - This retrospective study sought to identify clinical and urodynamic differences between female overactive bladder (OAB) patients with and without urodynamically proven detrusor overactivity (DO)... ...

read more UroToday.com - This retrospective study sought to identify clinical and urodynamic differences between female overactive bladder (OAB) patients with and without urodynamically proven detrusor overactivity (DO)... read more Fri Mar 2010

Innovative HeRO(R) Device Improves Outcomes, Quality Of Life For Kidney Disease Patients

Categorie : Urology / Nephrology
One thousand end stage renal disease patients have now benefited from a novel device that provides vital access to their blood for filtering and replacement kidney function, and reduces the risk of potentially fatal bacteremia infection. The HeRO® Vascular Access Device, produced by Hemosphere, In ...

read more One thousand end stage renal disease patients have now benefited from a novel device that provides vital access to their blood for filtering and replacement kidney function, and reduces the risk of potentially fatal bacteremia infection. The HeRO® Vascular Access Device, produced by Hemosphere, In read more Fri Mar 2010

Kidney Damage In 12% Of Chinese Children Exposed To Melamine-Contaminated Dairy Products

Categorie : Urology / Nephrology
While the majority of children who were affected by consuming toxic melamine-contaminated products in China recovered, kidney abnormalities remained in 12% of the affected children, according to an article in CMAJ. In 2008, melamine-contaminated dairy products from the Sanlu Dairy Company resulted i ...

read more While the majority of children who were affected by consuming toxic melamine-contaminated products in China recovered, kidney abnormalities remained in 12% of the affected children, according to an article in CMAJ. In 2008, melamine-contaminated dairy products from the Sanlu Dairy Company resulted i read more Fri Mar 2010

Study Examines Outcomes Associated With Anemia Management For Patients With End-Stage Renal Disease

Categorie : Urology / Nephrology
Greater use of erythropoiesis-stimulating agents (ESAs) and more frequent use of iron at lower hematocrit levels (the proportion of the blood that consists of red blood cells) was associated with a decreased risk of death for hemodialysis patients, according to a study in the March 3 issue of JAMA.. ...

read more Greater use of erythropoiesis-stimulating agents (ESAs) and more frequent use of iron at lower hematocrit levels (the proportion of the blood that consists of red blood cells) was associated with a decreased risk of death for hemodialysis patients, according to a study in the March 3 issue of JAMA.. read more Fri Mar 2010

Antares Pharma Announces Completion Of Patient Enrollment In Phase 3 Pivotal Trial Of Anturol™ For The Treatment Of Overactive Bladder

Categorie : Urology / Nephrology
Antares Pharma, Inc. (NYSE Amex: AIS) announced that it has completed enrollment in the double-blind portion of the Company's Phase 3 clinical trial of Anturol™, its transdermal oxybutynin ATD™ gel for the treatment of overactive bladder (OAB). Top line data from this pivotal trial, which is bei ...

read more Antares Pharma, Inc. (NYSE Amex: AIS) announced that it has completed enrollment in the double-blind portion of the Company's Phase 3 clinical trial of Anturol™, its transdermal oxybutynin ATD™ gel for the treatment of overactive bladder (OAB). Top line data from this pivotal trial, which is bei read more Fri Mar 2010

Impax Laboratories Receives Final FDA Approval For Generic FLOMAX(R) 0.4mg Capsules And Immediately Commences Shipment

Categorie : Urology / Nephrology
Impax Laboratories, Inc. (NASDAQ: IPXL) announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of FLOMAX® (tamsulosin hydrochloride) 0.4mg capsules. The Company also announced that it is ...

read more Impax Laboratories, Inc. (NASDAQ: IPXL) announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of FLOMAX® (tamsulosin hydrochloride) 0.4mg capsules. The Company also announced that it is read more Fri Mar 2010

The Expression Of Thrombospondin-1 And P53 In CCRCC: Its Relationship To Angiogenesis, Cell Proliferation, And Cancer Specific Survival

Categorie : Urology / Nephrology
UroToday.com - Clear cell renal cell carcinoma (CCRCC) is the most prevalent of the subtypes of renal cell carcinoma (RCC). Its prognosis is unpredictable because even small tumors may progress and end in metastatic disease and death. There is an urgent need for new molecular prognostic markers and ...

read more UroToday.com - Clear cell renal cell carcinoma (CCRCC) is the most prevalent of the subtypes of renal cell carcinoma (RCC). Its prognosis is unpredictable because even small tumors may progress and end in metastatic disease and death. There is an urgent need for new molecular prognostic markers and read more Wed Feb 2010

Effect Of Low Dose Radiation Computerized Tomography Protocols On Distal Ureteral Calculus Detection

Categorie : Urology / Nephrology
UroToday.com - Stone cancer! While chronic inflammation due to a renal pelvis stone may on very rare occasion be associated with the development of a squamous cell cancer of the collecting system, what is far more common and more worrisome is that our method of diagnosing a ureteral calculus could ...

read more UroToday.com - Stone cancer! While chronic inflammation due to a renal pelvis stone may on very rare occasion be associated with the development of a squamous cell cancer of the collecting system, what is far more common and more worrisome is that our method of diagnosing a ureteral calculus could read more Wed Feb 2010

Fresenius Medical Care Sends Dialysis Supplies For Haiti Relief Effort

Categorie : Urology / Nephrology
Fresenius Medical Care North America (FMCNA), the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, is donating and delivering dialysis supplies to Haitians, at a time when relief supplies continue to be slow to reach ...

read more Fresenius Medical Care North America (FMCNA), the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, is donating and delivering dialysis supplies to Haitians, at a time when relief supplies continue to be slow to reach read more Wed Feb 2010

DSG Partners With Biotech Company To Battle Progressive And Chronic Kidney Disease

Categorie : Urology / Nephrology
DSG's eCaseLink™ Electronic Data Capture (EDC) and data management are currently being used by a biotechnology company for two current phase 2 and phase 2a clinical trials for treatments of progressive and chronic kidney disease. The company uses DSG's eCaseLink™ to automate and manage the data ...

read more DSG's eCaseLink™ Electronic Data Capture (EDC) and data management are currently being used by a biotechnology company for two current phase 2 and phase 2a clinical trials for treatments of progressive and chronic kidney disease. The company uses DSG's eCaseLink™ to automate and manage the data read more Wed Feb 2010

Pervasis Therapeutics Receives FDA Clearance For Pivotal Phase 3 Trial Of Vascugel(R)

Categorie : Urology / Nephrology
Pervasis Therapeutics, Inc. announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the design of a pivotal Phase 3 clinical trial for Vascugel®, an investigational new drug for the prevention of hemodialysis access graft failure. The agreement was made under ...

read more Pervasis Therapeutics, Inc. announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the design of a pivotal Phase 3 clinical trial for Vascugel®, an investigational new drug for the prevention of hemodialysis access graft failure. The agreement was made under read more Wed Feb 2010

Vantia Therapeutics' Lead Candidate VA106483 Enters Phase IIb Trial For Nocturia

Categorie : Urology / Nephrology
Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, announces it has begun its planned Phase IIb trial of its lead development compound VA106483 for nocturia. The study is a randomised, double-blind, placebo-con ...

read more Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, announces it has begun its planned Phase IIb trial of its lead development compound VA106483 for nocturia. The study is a randomised, double-blind, placebo-con read more Wed Feb 2010

Kidney Cancer Drug Shows Promising Results

Categorie : Urology / Nephrology
The drug pazopanib (Votrient) slowed the progression of advanced renal cell carcinoma (RCC), a form of kidney cancer, in patients by 54% percent, according to a new study published in the Journal of Clinical Oncology... ...

read more The drug pazopanib (Votrient) slowed the progression of advanced renal cell carcinoma (RCC), a form of kidney cancer, in patients by 54% percent, according to a new study published in the Journal of Clinical Oncology... read more Wed Feb 2010

Paracetamol Protects Against Kidney Failure After Muscle Injury

Categorie : Urology / Nephrology
The commonly-used painkiller Paracetamol can protect against kidney failure after severe muscle injury, according to research at the University of Essex. One of the main causes of kidney failure affecting tens of thousands of people each year is a syndrome known as Rhabdomyolysis-Induced Renal Fai ...

read more The commonly-used painkiller Paracetamol can protect against kidney failure after severe muscle injury, according to research at the University of Essex. One of the main causes of kidney failure affecting tens of thousands of people each year is a syndrome known as Rhabdomyolysis-Induced Renal Fai read more Wed Feb 2010

NICE Consults On Preliminary Decision Not To Recommend Everolimus For Advanced Renal Cell Carcinoma

Categorie : Urology / Nephrology
In draft guidance, published today (9 February 2010), the National Institute for Health and Clinical Excellence (NICE) has been unable to recommend everolimus (afinitor, Novartis) for the second line treatment of advanced renal cell carcinoma. This draft guidance is now available for public consult ...

read more In draft guidance, published today (9 February 2010), the National Institute for Health and Clinical Excellence (NICE) has been unable to recommend everolimus (afinitor, Novartis) for the second line treatment of advanced renal cell carcinoma. This draft guidance is now available for public consult read more Wed Feb 2010

Research At UCSB Points To Potential Treatment For Kidney Disease

Categorie : Urology / Nephrology
Research performed at UC Santa Barbara points to the drug rapamycin as a potential treatment for kidney disease. The study builds on past research and shows that studies performed on mice are more likely to translate to humans than previously thought. The results are published in the current online ...

read more Research performed at UC Santa Barbara points to the drug rapamycin as a potential treatment for kidney disease. The study builds on past research and shows that studies performed on mice are more likely to translate to humans than previously thought. The results are published in the current online read more Thu Jan 2010

Repros Receives Guidance From FDA Regarding Continued Development Of Androxal(R) In Hypogonadal Men

Categorie : Urology / Nephrology
Repros Therapeutics Inc. (NasdaqCM:RPRX) announced that the Company and its consultants participated in a teleconference with the Division of Reproductive and Urologic Products of the FDA on January 25, 2010... ...

read more Repros Therapeutics Inc. (NasdaqCM:RPRX) announced that the Company and its consultants participated in a teleconference with the Division of Reproductive and Urologic Products of the FDA on January 25, 2010... read more Thu Jan 2010

Submit Your Nomination For The Excellence In Urology Health Reporting Awards

Categorie : Urology / Nephrology
Submissions are now being accepted for the 4th Annual Excellence in Urology Health Reporting Awards, presented by the American Urological Association (AUA). The awards, established in 2007 to recognize outstanding news coverage of urologic disease topics, will be presented at the 2010 AUA Annual Sci ...

read more Submissions are now being accepted for the 4th Annual Excellence in Urology Health Reporting Awards, presented by the American Urological Association (AUA). The awards, established in 2007 to recognize outstanding news coverage of urologic disease topics, will be presented at the 2010 AUA Annual Sci read more Sun Jan 2010

Spectrum Pharmaceuticals Completes Enrollment In Second Of Two Phase 3 Pivotal Trials For Apaziquone In Non-Muscle Invasive Bladder Cancer

Categorie : Urology / Nephrology
Spectrum Pharmaceuticals (NasdaqGM: SPPI) today announced that the second of two Phase 3 pivotal clinical trials of apaziquone has achieved its enrollment target. The two trials enrolled more than 1600 patients with non-muscle invasive bladder cancer. As per the collaboration agreement with Allergan ...

read more Spectrum Pharmaceuticals (NasdaqGM: SPPI) today announced that the second of two Phase 3 pivotal clinical trials of apaziquone has achieved its enrollment target. The two trials enrolled more than 1600 patients with non-muscle invasive bladder cancer. As per the collaboration agreement with Allergan read more Sun Jan 2010

1 | 2 | 3 | 4 next >>>

eHealth Guide News Abortion ADHD Aid / Disasters Alcohol / Addiction Allergy Alzheimer's Anxiety Arthritis Asthma / Respiratory Autism Bio-terrorism / Terrorism Biology / Biochemistry Bipolar Bird Flu / Avian Flu Blood / Hematology Body Aches Bones / Orthopaedics Breast Cancer Cancer / Oncology Cardiovascular / Cardiology Caregivers / Homecare Cholesterol CJD / vCJD / Mad Cow Disease Cleft Palate Clinical Trials / Drug Trials Colorectal Cancer Complementary Medicine / Alternative Medicine Compliance Conferences Cosmetic Medicine / Plastic Surgery Crohn's Cystic Fibrosis Dentistry Depression Dermatology Diabetes Dyslexia Ear, Nose and Throat Endocrinology Epilepsy Erectile Dysfunction / Premature Ejaculation Eye Health / Optometry Fertility Flu / SARS GastroIntestinal Genetics Gout Headache / Migraine Health Insurance / Medical Insurance Hearing / Deafness HIV / AIDS Huntingtons Disease Hypertension Immune System / Vaccines Infectious Diseases / Bacteria / Viruses Irritable-Bowel Syndrome Liver Disease / Hepatitis Lung Cancer Lupus Lymphoma / Leukemia Medical Devices Medical Malpractice / Litigation Medical Students Medicare / Medicaid / Tricare Men's health Mental Health MRI / PET / Ultrasound MRSA / Drug Resistance Multiple Sclerosis Muscular Dystrophy Neurology / Neuroscience Nursing Nutrition/Agriculture Obesity / Weight Loss / Fitness Pain / Anesthetics Parkinson's Disease Pediatrics Pharma Industry Pregnancy Primary Care / General Practice Prostate Psychology / Psychiatry Public Health Radiology / Nuclear Medicine Rehabilitation Schizophrenia Seniors / Aging Sexual Health / STDs Sleep / Sleep Disorders Smoking / Quit Smoking Sports Medicine / Fitness Statins Stem Cell Research Stroke / Neuroprotection Transplants / Organ Donations Tropical Diseases Urology / Nephrology Veterinary Water Quality / Air Quality Women's Health / OBGYN Health Policy Health Jobs Listing